Výsledky vyhledávání - Gomez‐Roca, Carlos
- Zobrazuji výsledky 1 - 20 z 20
-
1
-
2
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer Autor Leary, Alexandra, Le Tourneau, Christophe, Varga, Andrea, Sablin, Marie-Paule, Gomez-Roca, Carlos, Guilbaud, Nicolas, Petain, Aurelie, Pavlyuk, Mariya, Delord, Jean-Pierre
Vydáno 2018Text -
3
Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending Autor Ortiz Brugués, Ariadna, Sibaud, Vincent, Herbault‐Barrés, Beatrice, Betrian, Sarah, Korakis, Iphigenie, De Bataille, Caroline, Gomez‐Roca, Carlos, Epstein, Joel, Vigarios, Emmanuelle
Vydáno 2019Text -
4
Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancer Autor Martin, Nicolas, Isambert, Nicolas, Gomez-Roca, Carlos, Goeldner, Rainer-Georg, Zanetta, Sylvie, Sadrolhefazi, Behbood, de Mont-Serrat, Hélène, Campone, Mario, Delord, Jean-Pierre
Vydáno 2018Text -
5
Tumor Growth Rate (TGR) is an early indicator of anti-tumor drug activity in phase I clinical trials Autor Ferté, Charles, Fernandez, Marianna, Hollebecque, Antoine, Koscielny, Serge, Levy, Antonin, Massard, Christophe, Balheda, Rastislav, Bot, Brian, Gomez-Roca, Carlos, Dromain, Clarisse, Ammari, Samy, Soria, Jean-Charles
Vydáno 2013Text -
6
Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628 Autor Stathis, Anastasios, Zucca, Emanuele, Bekradda, Mohamed, Gomez-Roca, Carlos, Delord, Jean-Pierre, de La Motte Rouge, Thibault, Uro-Coste, Emmanuelle, de Braud, Filippo, Pelosi, Giuseppe, French, Christopher A.
Vydáno 2016Text -
7
Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer Autor Gomez‐Roca, Carlos, Even, Caroline, Le Tourneau, Christophe, Basté, Neus, Delord, Jean‐Pierre, Sarini, Jerome, Vergez, Sebastien, Temam, Stephane, Hoffmann, Caroline, Rochaix, Philippe, Borcoman, Edith, Gavillet, Bruno, Rouits, Elisabeth, Ménétrey, Annick, Brichory, Franck, Purcea, Daniela, Vuagniaux, Gregoire, Zanna, Claudio
Vydáno 2021Text -
8
Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia Autor Vey, Norbert, Delaunay, Jacques, Martinelli, Giovanni, Fiedler, Walter, Raffoux, Emmanuel, Prebet, Thomas, Gomez-Roca, Carlos, Papayannidis, Cristina, Kebenko, Maxim, Paschka, Peter, Christen, Randolph, Guarin, Ernesto, Bröske, Ann-Marie, Baehner, Monika, Brewster, Michael, Walz, Antje-Christine, Michielin, Francesca, Runza, Valeria, Meresse, Valerie, Recher, Christian
Vydáno 2016Text -
9
The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program Autor Aparicio, Thomas, Cozic, Nathalie, de la Fouchardière, Christelle, Meriaux, Emeline, Plaza, Jérome, Mineur, Laurent, Guimbaud, Rosine, Samalin, Emmanuelle, Mary, Florence, Lecomte, Thierry, Gomez-Roca, Carlos, Haineaux, Paul-Arthur, Gratet, Alain, Selves, Jannick, Menu, Yves, Colignon, Nikias, Johnson, Laetitia, Legrand, Frédéric, Vassal, Gilles
Vydáno 2021Text -
10
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma Autor O’Neil, Bert H., Wallmark, John M., Lorente, David, Elez, Elena, Raimbourg, Judith, Gomez-Roca, Carlos, Ejadi, Samuel, Piha-Paul, Sarina A., Stein, Mark N., Abdul Razak, Albiruni R., Dotti, Katia, Santoro, Armando, Cohen, Roger B., Gould, Marlena, Saraf, Sanatan, Stein, Karen, Han, Sae-Won
Vydáno 2017Text -
11
From presentation to paper: Gender disparities in oncological research Autor Dijksterhuis, Willemieke P.M., Stroes, Charlotte I., Tan, Wan‐Ling, Ithimakin, Suthinee, Calles, Antonio, van Oijen, Martijn G.H., Verhoeven, Rob H.A., Barriuso, Jorge, Oosting, Sjoukje F., Ivankovic, Daniela Kolarevic, Furness, Andrew J.S., Bozovic‐Spasojevic, Ivana, Gomez‐Roca, Carlos, van Laarhoven, Hanneke W.M.
Vydáno 2019Text -
12
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients w... Autor Le Tourneau, Christophe, Delord, Jean-Pierre, Kotecki, Nuria, Borcoman, Edith, Gomez-Roca, Carlos, Hescot, Ségolène, Jungels, Christiane, Vincent-Salomon, Anne, Cockenpot, Vincent, Eberst, Lauriane, Molé, Audrey, Jdey, Wael, Bono, Françoise, Trochon-Joseph, Véronique, Toussaint, Hélène, Zandanel, Christelle, Adamiec, Olga, de Beaumont, Olivier, Cassier, Philippe Alexandre
Vydáno 2020Text -
13
Phase I Study of the Immunotoxin LMB-100 in Patients with Mesothelioma and Other Solid Tumors Expressing Mesothelin Autor Hassan, Raffit, Alewine, Christine, Mian, Idrees, Spreafico, Anna, Siu, Lillian L., Gomez-Roca, Carlos, Delord, Jean-Pierre, Italiano, Antoine, Lassen, Ulrik, Soria, Jean-Charles, Bahleda, Rastilav, Thomas, Anish, Steinberg, Seth M., Peer, Cody J., Figg, William D., Niederfellner, Gerhard, Naegelen, Valérie Méresse, Pastan, Ira
Vydáno 2020Text -
14
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1(hi)CD39(+) CD4 T cells Autor Balança, Camille-Charlotte, Salvioni, Anna, Scarlata, Clara-Maria, Michelas, Marie, Martinez-Gomez, Carlos, Gomez-Roca, Carlos, Sarradin, Victor, Tosolini, Marie, Valle, Carine, Pont, Frédéric, Ferron, Gwénaël, Gladieff, Laurence, Vergez, Sébastien, Dupret-Bories, Agnès, Mery, Eliane, Rochaix, Philippe, Fournié, Jean-Jacques, Delord, Jean-Pierre, Devaud, Christel, Martinez, Alejandra, Ayyoub, Maha
Vydáno 2021Text -
15
First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors Autor Menke-van der Houven van Oordt, C. Willemien, Gomez-Roca, Carlos, van Herpen, Carla, Coveler, Andrew L., Mahalingam, Devalingam, Verheul, Henk M. W., van der Graaf, Winette T. A., Christen, Randolph, Rüttinger, Dominik, Weigand, Stefan, Cannarile, Michael A., Heil, Florian, Brewster, Michael, Walz, Antje-Christine, Nayak, Tapan K., Guarin, Ernesto, Meresse, Valerie, Le Tourneau, Christophe
Vydáno 2016Text -
16
Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients Autor Machiels, Jean-Pascal, Gomez-Roca, Carlos, Michot, Jean-Marie, Zamarin, Dmitriy, Mitchell, Tara, Catala, Gaetan, Eberst, Lauriane, Jacob, Wolfgang, Jegg, Anna-Maria, Cannarile, Michael A, Watson, Carl, Babitzki, Galina, Korski, Konstanty, Klaman, Irina, Teixeira, Priscila, Hoves, Sabine, Ries, Carola, Meneses-Lorente, Georgina, Michielin, Francesca, Christen, Randolph, Rüttinger, Dominik, Weisser, Martin, Delord, Jean-Pierre, Cassier, Philippe
Vydáno 2020Text -
17
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simulta... Autor Laprie, Anne, Ken, Soléakhéna, Filleron, Thomas, Lubrano, Vincent, Vieillevigne, Laure, Tensaouti, Fatima, Catalaa, Isabelle, Boetto, Sergio, Khalifa, Jonathan, Attal, Justine, Peyraga, Guillaume, Gomez-Roca, Carlos, Uro-Coste, Emmanuelle, Noel, Georges, Truc, Gilles, Sunyach, Marie-Pierre, Magné, Nicolas, Charissoux, Marie, Supiot, Stéphane, Bernier, Valérie, Mounier, Muriel, Poublanc, Muriel, Fabre, Amandine, Delord, Jean-Pierre, Cohen-Jonathan Moyal, Elizabeth
Vydáno 2019Text -
18
ACTR-30. UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG) Autor Wen, Patrick, Stein, Alexander, van den Bent, Martin, De Greve, Jacques, Dietrich, Sascha, De Vos, Filip, von Bubnoff, Nikolas, van Linde, Myra, Lai, Albert, Prager, Gerald, Campone, Mario, Fasolo, Angelica, Lopez-Martin, Jose, Min Kim, Tae, Mason, Warren, Hofheinz, Ralf-Dieter, Blay, Jean-Yves, Cho, Daniel, Gazzah, Anas, Gomez-Roca, Carlos, Yachnin, Jeffrey, Boran, Aislyn, Burgess, Paul, Palanichamy, Ilan, Gasal, Eduard, Subbiah, Vivek
Vydáno 2019Text -
19
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade Autor Gomez-Roca, Carlos, Cassier, Philippe, Zamarin, Dmitriy, Machiels, Jean-Pascal, Luis Perez Gracia, Jose, Stephen Hodi, F, Taus, Alvaro, Martinez Garcia, Maria, Boni, Valentina, Eder, Joseph P, Hafez, Navid, Sullivan, Ryan, Mcdermott, David, Champiat, Stephane, Aspeslagh, Sandrine, Terret, Catherine, Jegg, Anna-Maria, Jacob, Wolfgang, Cannarile, Michael A, Ries, Carola, Korski, Konstanty, Michielin, Francesca, Christen, Randolph, Babitzki, Galina, Watson, Carl, Meneses-Lorente, Georgina, Weisser, Martin, Rüttinger, Dominik, Delord, Jean-Pierre, Marabelle, Aurelien
Vydáno 2022Text -
20
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon Autor Rousseau, Benoit, Bieche, Ivan, Pasmant, Eric, Hamzaoui, Nadim, Leulliot, Nicolas, Michon, Lucas, de Reynies, Aurelien, Attignon, Valerie, Foote, Michael B., Masliah-Planchon, Julien, Svrcek, Magali, Cohen, Romain, Simmet, Victor, Augereau, Paule, Malka, David, Hollebecque, Antoine, Pouessel, Damien, Gomez-Roca, Carlos, Guimbaud, Rosine, Bruyas, Amandine, Guillet, Marielle, Grob, Jean-Jacques, Duluc, Muriel, Cousin, Sophie, de la Fouchardiere, Christelle, Flechon, Aude, Rolland, Frederic, Hiret, Sandrine, Saada-Bouzid, Esma, Bouche, Olivier, Andre, Thierry, Pannier, Diane, El Hajbi, Farid, Oudard, Stephane, Tournigand, Christophe, Soria, Jean-Charles, Champiat, Stephane, Gerber, Drew G., Stephens, Dennis, Lamendola-Essel, Michelle F., Maron, Steven B., Diplas, Bill H., Argiles, Guillem, Krishnan, Asha R., Tabone-Eglinger, Severine, Ferrari, Anthony, Segal, Neil H., Cercek, Andrea, Hoog-Labouret, Natalie, Legrand, Frederic, Simon, Clotilde, Lamrani-Ghaouti, Assia, Diaz, Luis A., Saintigny, Pierre, Chevret, Sylvie, Marabelle, Aurelien
Vydáno 2022Text